Eye shadow

Shimmy Eyeshadow Palette

(231)
Select a shade:

Complimentary shipping on orders of $100 or more. Read the returns policy before you buy.

Need help? Contact us

The formula

A pressed-powder eyeshadow palette that pairs velvety mattes with luminous, pearled shimmers in one coordinated set. Highly pigmented and buildable, each shade lays down smooth, blends cleanly, and layers from a soft daytime wash to a fully defined evening eye. A jojoba and silicone binder keeps the powder soft and adherent, so the shades build and blend smoothly without patchiness.

Shimmy is built around warm, luminous rosy-brown tones.

Finish: matte and shimmer · Coverage: buildable
Paraben-free. Cruelty-free. Made in North America.

The science

  • Up to 67% concentration evaluated

    Mica and Synthetic Fluorphlogopite confirmed safe as used in leave-on cosmetic formulations including eye-area products, with both ingredients covered under the same CIR safety assessment published in the International Journal of Toxicology.1

  • 51 triglycerides assessed

    Caprylic/Capric Triglyceride confirmed safe across all current cosmetic practices of use and concentration as part of a CIR comprehensive safety assessment covering 51 evaluated triglyceride esters with no skin sensitization identified at use-level concentrations.2

  • Measurable stratum corneum antioxidant activity

    Tocopherol confirmed to provide antioxidant protection in the skin's lipid-rich surface layer in leave-on cosmetic applications at concentrations below 1%, supporting formula stability and protection against oxidative degradation during wear.3

  • 7 FDA-approved colorants

    Every colorant across both matte and shimmer finish pans carries a specific FDA CFR permanent listing or batch certification exemption, with all seven approved for eye-area cosmetic use under applicable federal regulations.4

1Becker LC et al. International Journal of Toxicology, 2015. PMID: 26684795

2Fiume MZ et al. International Journal of Toxicology, 2022. DOI: 10.1177/10915818221123790

3Thiele JJ et al. Current Problems in Dermatology, 2001. DOI: 10.1159/000060651

4FDA 21 CFR 73.2575; FDA 21 CFR 73.2250; FDA 21 CFR 74.2052; FDA 21 CFR 74.2101; FDA 21 CFR 73.2299; FDA 21 CFR 74.2340; FDA 21 CFR 74.2705.

REVIEWS

Loading reviews…